| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Anatomy, University of Arizona, College of Medicine, Tucson, Arizona 85724
Since melatonin, the major hormone of the pineal gland, has been shown to inhibit the growth of mammary tumors in animal models of human breast cancer, we examined the hypothesis that this indoleamine has the potential to inhibit breast cancer growth by directly inhibiting cell proliferation as exemplified by the growth of the estrogen-responsive human breast cancer cell line MCF-7 in culture. Concentrations of melatonin (10-9 M; 10-11 M), corresponding to the physiological levels present in human blood during the evening hours, significantly inhibited (P < 0.001) cell proliferation by as much as 60% to 78% as measured by either DNA content or hemocytometer cell counts. Melatonin's inhibitory effect was reversible since the logarithmic growth of MCF-7 cells was restored after melatonin-containing medium was replaced with fresh medium lacking melatonin. Not only was the inhibitory effect of melatonin absent at either pharmacological (10-7 M; 10-5 M) or subphysiological (10-15 M; 10-13 M) concentrations, but melatonin also failed to inhibit the proliferation of either human foreskin fibroblasts or the estrogen receptor-positive human endometrial cancer cell line RL95-2. Both transmission and scanning electron microscopy revealed several morphological changes that correlated with melatonin's inhibition of cell growth. After just 4 days of exposure to melatonin, MCF-7 cells exhibited reduced numbers of surface microvilli, nuclear swelling, cytoplasmic and ribosomal shedding, disruption of mitochondrial cristae, vesiculation of the smooth endoplasmic reticulum, and an increase in the numbers of autophagic vacuoles. These results support the hypothesis that melatonin, at physiological concentrations, exerts a direct but reversible, antiproliferative effect on MCF-7 cell growth in culture. This antiproliferative effect is associated with striking changes in the ultrastructural features of these cells suggestive of a sublethal but reversible cellular injury.
1 Present address: Department of Biology, Abilene Christian University, Abilene, TX 79601.
2 Recipient of USPHS Grant R01CA-42424 from the National Cancer Institute.
Received 2/29/88. Revised 7/ 1/88. Accepted 7/ 6/88.
This article has been cited by other articles:
|
|
 |
|
  V. Srinivasan, D W. Spence, S. R. Pandi-Perumal, I. Trakht, and D. P. Cardinali Therapeutic Actions of Melatonin in Cancer: Possible Mechanisms Integr Cancer Ther, September 1, 2008; 7(3): 189 - 203. [Abstract] [PDF]
|
|
|
|
 |
|
 T. Kubo, K. Ozasa, K. Mikami, K. Wakai, Y. Fujino, Y. Watanabe, T. Miki, M. Nakao, K. Hayashi, K. Suzuki, et al. Prospective Cohort Study of the Risk of Prostate Cancer among Rotating-Shift Workers: Findings from the Japan Collaborative Cohort Study Am. J. Epidemiol., September 15, 2006; 164(6): 549 - 555. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Martin, F. Herrera, P. Carrera-Gonzalez, G. Garcia-Santos, I. Antolin, J. Rodriguez-Blanco, and C. Rodriguez Intracellular Signaling Pathways Involved in the Cell Growth Inhibition of Glioma Cells by Melatonin Cancer Res., January 15, 2006; 66(2): 1081 - 1088. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. E. Blask, G. C. Brainard, R. T. Dauchy, J. P. Hanifin, L. K. Davidson, J. A. Krause, L. A. Sauer, M. A. Rivera-Bermudez, M. L. Dubocovich, S. A. Jasser, et al. Melatonin-Depleted Blood from Premenopausal Women Exposed to Light at Night Stimulates Growth of Human Breast Cancer Xenografts in Nude Rats Cancer Res., December 1, 2005; 65(23): 11174 - 11184. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. del Rio, J. M. G. Pedrero, C. Martinez-Campa, P. Zuazua, P. S. Lazo, and S. Ramos Melatonin, an Endogenous-specific Inhibitor of Estrogen Receptor {alpha} via Calmodulin J. Biol. Chem., September 10, 2004; 279(37): 38294 - 38302. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Izzo, M. d'Istria, I. Serino, and S. Minucci Inhibition of the increased 17{beta}-estradiol-induced mast cell number by melatonin in the testis of the frog Rana esculenta, in vivo and in vitro J. Exp. Biol., February 1, 2004; 207(3): 437 - 441. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Fedrowitz, K. Kamino, and W. Loscher Significant Differences in the Effects of Magnetic Field Exposure on 7,12-Dimethylbenz(a)anthracene-Induced Mammary Carcinogenesis in Two Substrains of Sprague-Dawley Rats Cancer Res., January 1, 2004; 64(1): 243 - 251. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Canaple, T. Kakizawa, and V. Laudet The Days and Nights of Cancer Cells Cancer Res., November 15, 2003; 63(22): 7545 - 7552. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. S. Schernhammer, F. Laden, F. E. Speizer, W. C. Willett, D. J. Hunter, I. Kawachi, C. S. Fuchs, and G. A. Colditz Night-Shift Work and Risk of Colorectal Cancer in the Nurses' Health Study J Natl Cancer Inst, June 4, 2003; 95(11): 825 - 828. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Simonneaux and C. Ribelayga Generation of the Melatonin Endocrine Message in Mammals: A Review of the Complex Regulation of Melatonin Synthesis by Norepinephrine, Peptides, and Other Pineal Transmitters Pharmacol. Rev., June 1, 2003; 55(2): 325 - 395. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. McElroy, P. A. Newcomb, A. Trentham-Dietz, J. M. Hampton, M. S. Kanarek, and P. L. Remington Endometrial Cancer Incidence in Relation to Electric Blanket Use Am. J. Epidemiol., August 1, 2002; 156(3): 262 - 267. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Vijayalaxmi, C. R. Thomas Jr, R. J. Reiter, and T. S. Herman Melatonin: From Basic Research to Cancer Treatment Clinics J. Clin. Oncol., May 15, 2002; 20(10): 2575 - 2601. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Fedrowitz, J. Westermann, and W. Loscher Magnetic Field Exposure Increases Cell Proliferation but Does Not Affect Melatonin Levels in the Mammary Gland of Female Sprague Dawley Rats Cancer Res., March 1, 2002; 62(5): 1356 - 1363. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Davis, D. K. Mirick, and R. G. Stevens Residential Magnetic Fields and the Risk of Breast Cancer Am. J. Epidemiol., March 1, 2002; 155(5): 446 - 454. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Ishido, H. Nitta, and M. Kabuto Magnetic fields (MF) of 50 Hz at 1.2 {micro}T as well as 100 {micro}T cause uncoupling of inhibitory pathways of adenylyl cyclase mediated by melatonin 1a receptor in MF-sensitive MCF-7 cells Carcinogenesis, July 1, 2001; 22(7): 1043 - 1048. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Hartveit Annual Rhythm in the Growth of Human Breast Carcinomas as Reflected in the Histology of Their Growing Edge International Journal of Surgical Pathology, January 1, 2000; 8(1): 39 - 47. [Abstract] [PDF]
|
|
|
|
 |
|
 R. M. ASAINZ, J. C. MAYO, R. J. REITER, I. ANTOLÍN, M. M. ESTEBAN, and C. RODRÍGUEZ Melatonin regulates glucocorticoid receptor: an answer to its antiapoptotic action in thymus FASEB J, September 1, 1999; 13(12): 1547 - 1556. [Abstract] [Full Text]
|
|
|
|
|
|
J. A. Roth, B.-G. Kim, W.-L. Lin, and M.-I. Cho Melatonin Promotes Osteoblast Differentiation and Bone Formation J. Biol. Chem., July 30, 1999; 274(31): 22041 - 22047. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. GARCÍA RATO, J. GARCÍA PEDRERO, M. A. MARTÍNEZ, B. DEL RIO, P. S. LAZO, and S. RAMOS Melatonin blocks the activation of estrogen receptor for DNA binding FASEB J, May 1, 1999; 13(8): 857 - 868. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. De Salvia, M. Fiore, T. Aglitti, F. Festa, R. Ricordy, and R. Cozzi Inhibitory action of melatonin on H2O2- and cyclophosphamide-induced DNA damage Mutagenesis, January 1, 1999; 14(1): 107 - 112. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Brzezinski Melatonin in Humans N. Engl. J. Med., January 16, 1997; 336(3): 186 - 195. [Full Text] [PDF]
|
|
|
|
|
|
M. Schrader, C. Danielsson, I. Wiesenberg, and C. Carlberg Identification of Natural Monomeric Response Elements of the Nuclear Receptor RZR/ROR. THEY ALSO BIND COUP-TF HOMODIMERS J. Biol. Chem., August 16, 1996; 271(33): 19732 - 19736. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Missbach, B. Jagher, I. Sigg, S. Nayeri, C. Carlberg, and I. Wiesenberg Thiazolidine Diones, Specific Ligands of the Nuclear Receptor Retinoid Z Receptor/Retinoid Acid Receptor-related Orphan Receptor alpha with Potent Antiarthritic Activity J. Biol. Chem., June 7, 1996; 271(23): 13515 - 13522. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Nelson and J. M. C. Blom Photoperiodic Effects on Tumor Development and Immune Function J Biol Rhythms, December 1, 1994; 9(3-4): 233 - 249. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
